Showing results (171-180 of 207) with videos related to
Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer modelSeiji Mabuchi, Yoshito Terai, Kenichiro Morishige, et al.Journal of Ovarian Research|November 21, 2012
GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancerSatoe Fujiwara, Yoshito Terai, Hiroshi Kawaguchi, et al.Journal of Clinical Medicine|July 13, 2024
Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node BiopsyTomohito Tanaka, Ruri Nishie, Hikaru Murakami, et al.Oncogene|March 30, 2004
Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell linesAkiko Kimura, Masahide Ohmichi, Jun Kawagoe, et al.Endocrinology|January 1, 2004
Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatinEmi Arimoto-Ishida, Masahide Ohmichi, Seiji Mabuchi, et al.BMC Pregnancy and Childbirth|November 12, 2025
Exploratory study of the oral microbiota in pregnant women with hypothyroidism and their infantsMayu Ohmichi-Tomiwa, Nahoko Kato-Kogoe, Asako Kudo, et al.Journal of Cardiology Cases|December 12, 2018
Cardiac metastasis of uterine cervical squamous cell carcinoma: A case report and review of the literatureYoshihiro Takeda, Ryu-Ichiro Fujimoto, Hideaki Morita, et al.The Journal of Endocrinology|December 14, 2004
Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascadeBotao Du, Masahide Ohmichi, Kazuhiro Takahashi, et al.Endocrinology|January 7, 2006
Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer modelsTsuyoshi Ohta, Masahide Ohmichi, Tadashi Hayasaka, et al.Oncology Reports|April 26, 2017
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathwaysKiyoko Nakamura, Yoshito Terai, Akiko Tanabe, et al.Pageof 21